ABBV

AVOID

AbbVie Inc.

Health Care

3.69

PEGY ratio

Rank #416

Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Strong projected growth of 695.6% annually over 5 years. Attractive dividend yield of 3.3%.

ABBV trades at 104.4x earnings against 25.0% capped growth (actual 695.6%) + 3.3% yield (PEGY 3.69). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.
• Growth rate capped at 25% for PEGY calculation (actual: 695.6%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.

Scan date: 2026-06-02

Valuation

104.4x

P/E Ratio

Growth

695.6%

5yr EPS

Income

3.3%

Div Yield

PEGY Components

PEGY Score3.69

Denominator28.3%

EPS (TTM)$2.04

Market Data

Price$212.93

ExchangeNYSE

S&P 500

What Changed

PEGY Score

3.73→3.69(-0.04)

Rank

#415→#416(1 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only